Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes - Commentary

Research output: Contribution to journalArticle

1 Scopus citations
Original languageEnglish (US)
JournalAnnals of Internal Medicine
Volume152
Issue number6
StatePublished - Mar 16 2010

ASJC Scopus subject areas

  • Internal Medicine

Cite this